<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Oncology Caregiving: Supporting Patients through Acute and Chronic Cancer | AccrediPro</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
 /* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

 /* Reset & Base */
 * {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
 }

 body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
 }

 /* MAIN WRAPPER */
 .lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding-bottom: 80px;
 }

 /* HEADER CARD - Premium Gradient */
 .module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
 }

 .module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
 }

 .module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
 }

 .lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
 }

 /* META BADGES */
 .lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
 }

 .meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
 }

 /* ASI CREDENTIAL STRIP */
 .asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
 }

 .asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
 }

 .asi-text {
 flex: 1;
 }

 .asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
 }

 .asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
 }

 /* TABLE OF CONTENTS */
 .toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
 }

 .toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
 }

 .toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
 }

 .toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
 }

 .toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
 }

 .section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
 }

 /* WELCOME BOX */
 .welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
 }

 .welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
 }

 /* OBJECTIVES BOX */
 .objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
 }

 .box-label {
 font-weight: 700;
 color: #7e22ce;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
 }

 .objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
 }

 .objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
 }

 .objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
 }

 /* HIGHLIGHT */
 .highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
 }

 /* TYPOGRAPHY */
 h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
 }

 h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
 }

 h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
 }

 p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
 }

 /* CASE STUDY */
 .case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
 }

 .case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
 }

 .case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
 }

 .case-study-content {
 padding: 28px;
 }

 /* TABLES */
 .data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
 .data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
 .data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
 .data-table tr:nth-child(even) { background: #f9fafb; }

 /* COACH TIP BOX */
 .coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
 }

 .coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
 }

 /* MODULE CONNECTION BOX */
 .module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
 }

 /* CHECK YOUR UNDERSTANDING */
 .check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
 }
 .check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
 }
 .question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
 }
 .reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
 }
 .answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
 }

 /* KEY TAKEAWAYS */
 .takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
 }
 .takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
 }
 .takeaways-box ul {
 margin: 0;
 padding-left: 20px;
 list-style: disc;
 }
 .takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
 }

 /* REFERENCES */
 .references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
 }
 .references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
 display: flex;
 align-items: center;
 gap: 8px;
 }
 .references-box ol {
 padding-left: 20px;
 }
 .references-box li {
 font-size: 14px;
 color: #475569;
 margin-bottom: 8px;
 }

 @media (max-width: 768px) {
 .lesson-wrapper { padding: 16px; }
 .lesson-title { font-size: 28px; }
 .toc-list { grid-template-columns: 1fr; }
 }
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 27: Specialty Applications</span>
 <h1 class="lesson-title">Oncology Caregiving: Supporting Patients through Acute and Chronic Cancer</h1>
 <div class="lesson-meta">
 <span class="meta-badge">‚è±Ô∏è 14 min read</span>
 <span class="meta-badge">üéì Lesson 4 of 8</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Credential</div>
 <div class="title">AccrediPro Standards Institute ‚Ä¢ Oncology Support Specialist</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="toc-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#situational-analysis"><span class="section-num">01</span>Situational Analysis & Side Effects</a></li>
 <li><a href="#financial-toxicity"><span class="section-num">02</span>Managing Financial Toxicity</a></li>
 <li><a href="#empowered-advocacy"><span class="section-num">03</span>Advocacy in Genomic Testing</a></li>
 <li><a href="#survivorship-palliative"><span class="section-num">04</span>Survivorship & Palliative Care</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-text">
 <p>While previous lessons focused on neurodegenerative and pediatric complexities, <strong>Oncology Caregiving</strong> requires a unique "Care CEO" approach due to the high intensity of treatment cycles and the long-term metabolic impact of cancer therapies.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>The Oncology Support Landscape</h3>
 <p>Welcome to one of the most critical lessons in your certification. As an Oncology Support Specialist, you aren't just a caregiver; you are the <strong>strategic orchestrator</strong> of a complex clinical and emotional landscape. This lesson will equip you with the advanced tools needed to navigate "chemo-brain," manage the "financial toxicity" of modern cancer care, and lead the charge in genomic advocacy.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <p class="box-label">Learning Objectives</p>
 <ul>
 <li>Conduct a Situational Analysis of treatment-induced side effects like neuropathy and cognitive impairment.</li>
 <li>Implement strategies to mitigate the "financial toxicity" of cancer using pharmaceutical assistance programs.</li>
 <li>Master the interpretation of genomic testing and pathology results for empowered clinical advocacy.</li>
 <li>Design a survivorship blueprint that addresses the physiological and emotional "cliff" after treatment ends.</li>
 <li>Analyze the transition to palliative care through the lens of the S.O.L.A.C.E. Framework‚Ñ¢.</li>
 </ul>
 </div>

 <!-- Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="title">Case Study: Brenda's Strategic Shift</div>
 </div>
 <div class="case-study-content">
 <p><strong>Client:</strong> Brenda, 52 (Former High School Teacher)</p>
 <p><strong>Scenario:</strong> Brenda‚Äôs husband, Mark (55), was diagnosed with Stage III Colorectal Cancer. Brenda felt overwhelmed by the "alphabet soup" of oncology‚ÄîFOLFOX, CEA levels, and HER2 markers. She was spending 40 hours a week just managing appointments.</p>
 <p><strong>Intervention:</strong> Applying the S.O.L.A.C.E. Framework‚Ñ¢, Brenda shifted to a "Care CEO" mindset. She mapped Mark's neuropathy using a functional log and leveraged a pharmaceutical co-pay card that saved them $1,200 per month.</p>
 <p><strong>Outcome:</strong> By the time Mark reached survivorship, Brenda had secured a role as a private Caregiver Consultant, earning $75/hour helping other families navigate the same maze she once feared.</p>
 </div>
 </div>

 <h2 id="situational-analysis">Situational Analysis: Mapping Treatment Side Effects</h2>
 <p>In oncology, the "Situational Analysis" (the 'S' in S.O.L.A.C.E.‚Ñ¢) must be granular. We aren't just looking at the cancer; we are looking at the <strong>collateral damage</strong> of the treatment. Two of the most debilitating side effects that impact the caregiver's workload are <span class="highlight">Chemotherapy-Induced Peripheral Neuropathy (CIPN)</span> and <span class="highlight">Cancer-Related Cognitive Impairment (CRCI)</span>, commonly known as "chemo-brain."</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Side Effect</th>
 <th>Clinical Presentation</th>
 <th>Caregiver Impact</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>CIPN (Neuropathy)</strong></td>
 <td>Numbness, tingling, "pins and needles" in hands/feet.</td>
 <td>Increased fall risk; assistance needed with fine motor tasks (buttoning, eating).</td>
 </tr>
 <tr>
 <td><strong>CRCI (Chemo-brain)</strong></td>
 <td>Memory lapses, inability to multitask, "foggy" thinking.</td>
 <td>Need for medication oversight; increased advocacy during medical appointments.</td>
 </tr>
 <tr>
 <td><strong>Myelosuppression</strong></td>
 <td>Low white/red blood cell counts (neutropenia/anemia).</td>
 <td>Strict environmental mapping; infection control; monitoring for fatigue/shortness of breath.</td>
 </tr>
 </tbody>
 </table>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip</span>
 <p>üí° Use a "Functional Symptom Log." Instead of just asking if they have pain, ask: "On a scale of 1-10, how much did the tingling in your feet interfere with your ability to walk to the bathroom today?" This data is invaluable for the oncologist during dose-adjustment conversations.</p>
 </div>

 <h2 id="financial-toxicity">Leveraging Resources: Navigating Financial Toxicity</h2>
 <p>A 2023 study found that nearly <span class="highlight">42% of cancer patients</span> deplete their entire life savings within two years of diagnosis. This "financial toxicity" is a physiological stressor that can impede recovery. As a specialist, your role is to identify <strong>Leveraged Resources</strong> (the 'L' in S.O.L.A.C.E.‚Ñ¢).</p>
 
 <p>Key financial levers include:</p>
 <ul>
 <li><strong>Pharmaceutical Assistance Programs (PAPs):</strong> Manufacturers often provide "co-pay cards" or free drugs to patients who meet certain income thresholds.</li>
 <li><strong>Foundational Grants:</strong> Organizations like the Patient Access Network (PAN) Foundation provide grants for specific cancer types to cover premiums and medications.</li>
 <li><strong>Social Security Disability Insurance (SSDI) Compassionate Allowances:</strong> Certain cancers qualify for expedited processing, providing income support much faster than traditional disability.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip</span>
 <p>üí° Never accept the "sticker price" for a specialty drug. Always check the manufacturer's website for a "Patient Support" link. These programs are often under-utilized because families are too overwhelmed to search for them.</p>
 </div>

 <h2 id="empowered-advocacy">Empowered Advocacy: Genomic Testing & Clinical Trials</h2>
 <p>Modern oncology is moving toward <strong>Precision Medicine</strong>. Empowered Advocacy (the 'E' in S.O.L.A.C.E.‚Ñ¢) requires the specialist to understand the difference between a pathology report and a genomic profile.</p>
 
 <p><strong>Pathology</strong> tells us what the cell looks like under a microscope. <strong>Genomics</strong> tells us what mutations are driving the cancer growth (e.g., KRAS, EGFR, ALK). Understanding these markers allows you to advocate for targeted therapies that may have fewer side effects than traditional chemotherapy.</p>

 <h3>The Clinical Trial Ladder</h3>
 <p>Many families view clinical trials as a "last resort." In reality, trials often provide access to the <strong>standard of care plus</strong> a new, potentially more effective agent. Use the <em>ClinicalTrials.gov</em> database to search for phase II and III trials that match the patient's specific genomic markers.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip</span>
 <p>üí° When reading a pathology report, look for the "Ki-67" index. This is a marker of how fast the cells are dividing. A high percentage often means a more aggressive approach is needed, whereas a low percentage may allow for more "watchful waiting."</p>
 </div>

 <h2 id="survivorship-palliative">Actionable Self-Care: The Transition Cliff</h2>
 <p>The transition from "active treatment" to "survivorship" is often the most stressful time for caregivers. During treatment, there is a clear plan and a team. Once treatment ends, the patient and caregiver often feel abandoned‚Äîa phenomenon known as the <strong>Survivorship Cliff</strong>.</p>

 <p><strong>Actionable Self-Care (the 'A' in S.O.L.A.C.E.‚Ñ¢)</strong> during this phase must focus on:</p>
 <ul>
 <li><strong>Metabolic Restoration:</strong> Addressing the long-term mitochondrial damage from chemo.</li>
 <li><strong>Fear of Recurrence (FCR):</strong> Developing coping mechanisms for "scanxiety."</li>
 <li><strong>Palliative Care Integration:</strong> Remind the family that palliative care is <em>not</em> hospice; it is a layer of support for symptom management that can be used alongside curative treatment.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip</span>
 <p>üí° For the caregiver, survivorship is the time to "re-fill the well." Encourage the 5-Minute Reset (from Module 4) specifically during the weeks leading up to follow-up scans to manage the physiological spike in cortisol.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. What is "Financial Toxicity" and why is it relevant to a Caregiver Support Specialist?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Financial toxicity refers to the severe financial distress caused by the cost of cancer treatment. It is relevant because financial stress acts as a physiological stressor on both the patient and caregiver, and the Specialist can mitigate this by leveraging pharmaceutical assistance programs and grants.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. How does Genomic Testing differ from a standard Pathology Report?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Pathology looks at the physical appearance of cells, while Genomic Testing looks at the DNA mutations (like BRCA or EGFR) driving the cancer. Understanding genomics allows for "Empowered Advocacy" for targeted, precision therapies.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. What is the "Survivorship Cliff"?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">It is the period after active treatment ends where the intensive medical support drops off, leaving patients and caregivers feeling isolated, anxious, and physically depleted as they navigate the "new normal."</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. True or False: Palliative Care is only for patients who are at the end of life.</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">False. Palliative care is a supportive layer for symptom and stress management that can‚Äîand should‚Äîbe integrated at any stage of a serious illness, including alongside curative treatment.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li>Oncology caregiving requires a "Care CEO" mindset to manage the intersection of clinical, financial, and emotional data.</li>
 <li>Situational Analysis must include mapping treatment side effects like neuropathy and chemo-brain to adjust daily care routines.</li>
 <li>Leveraging financial resources (PAPs, grants) is a core competency for reducing the household's "financial toxicity."</li>
 <li>Advocacy in the modern oncology era requires a basic understanding of genomic markers and clinical trial accessibility.</li>
 <li>Survivorship is a high-risk period for caregiver burnout and requires proactive "Actionable Self-Care" strategies.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Zafar, S. Y. (2023). "The Financial Toxicity of Cancer Treatment: A Review of the Evidence." <em>Journal of Clinical Oncology.</em></li>
 <li>Ahles, T. A., et al. (2022). "Cancer- and Cancer Treatment-Associated Cognitive Change." <em>Journal of Clinical Oncology.</em></li>
 <li>National Cancer Institute. (2024). "Understanding Genomic Testing in Cancer Care." <em>NCI Clinical Guidelines.</em></li>
 <li>Stiefel, F., et al. (2021). "The Caregiver's Burden in Oncology: A Meta-Analysis of Intervention Studies." <em>Psycho-Oncology.</em></li>
 <li>American Society of Clinical Oncology (ASCO). (2023). "Palliative Care in Oncology: ASCO Guideline Update."</li>
 <li>Lustberg, M. B., et al. (2022). "Chemotherapy-Induced Peripheral Neuropathy: Epidemiology and Management." <em>Nature Reviews Clinical Oncology.</em></li>
 </ol>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 const isVisible = answer.style.display === 'block';
 answer.style.display = isVisible ? 'none' : 'block';
 this.textContent = isVisible ? 'Reveal Answer' : 'Hide Answer';
 }
 });
 });
</script>

</body>
</html>